Editorial: Antibody Validation Requirements for Articles Published in Endocrinology
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Progress in scientific research is hindered when authors fail to perform proper quality controls in their work. This calls into question whether their results are meaningful, and makes it difficult or impossible for others to replicate or extend work based on the initial finding. Beginning with this editorial and over the next few months, I will announce new and simple requirements for authors that will give greater confidence to readers that their results are “real” based on unambiguous descriptions of their methodology. My first initiative involves the use of antibodies in research. When submitting original research articles or technical reports, authors will be required to fill in a table (Table 1) and to include some prose description about each antibody's specificity and validation. Articles will be published with the antibody table included in the text, and we will begin consolidating this information into a searchable database as a resource for investigators seeking to find validated antibodies for their research. I have based my initiative on a similar one described in detail in The Journal of Comparative Neurology (1), and we refer our readers to their website: onlinelibrary.wiley.com/journal/10.1002/(ISSN)1096-9861/homepage/jcn_antibody_database.htm. Required Table of Information about Antibodies Required Table of Information about Antibodies It is critical that an antibody is specific to its target antigen (2). Characterization and validation can be done in the authors' lab for untested antibodies, or can be based on prior published work on the same antibody. In some cases, the manufacturer's information can be useful, but should be interpreted with caution. For example, citation of an article demonstrating a single band at the appropriate molecular weight on a Western blot, or RIA/enzyme immunoassay results, would be acceptable with adequate prose description of the result. Proper controls also need to be performed, such as preadsorption of the antibody with the original antigen, lack of labeling in tissue from knockout animals, comparisons of the distribution of antibody labeling to known mRNA distribution using in situ hybridization, or identical distribution patterns seen using two antibodies designed against different antigen sites or two antibodies made in two different species (2). Along with completion of this table, authors would need to provide 1 to 2 sentences describing characterization and controls. Although this initiative adds an extra step to the article submission process, such a quality control has considerable value to both authors and readers. It enables others to replicate the authors' work, and it gives confidence in applying the same antibody to future work. It also ensures that key details are included. In efforts to save space, Methods sections have become increasingly truncated. By requiring authors to fill out a table and add a few descriptive sentences, this ensures that no critical omission occurs in the case of antibody use. Last month's edition of Endocrinology included an article by Panjwani et al (3), further discussed in the News and Views article by Pyke and Knudsen (4), that underscored the importance of antibody validation. In that original research report (3), a series of commonly used antibodies to GLP-1R were tested comprehensively, and several did not hold up to scrutiny for sensitivity and specificity. These results challenge all previous research performed with these latter antibodies. I personally know of published papers that are questionable or even unbelievable because of the lack of proper validation of antibodies and the inability of others to replicate their work. Such articles do not serve the scientific community. I firmly believe that this new antibody initiative will ensure that only the highest quality research continues to be published in Endocrinology. I thank Dr. Patrick Hof, Editor-in-Chief of The Journal of Comparative Neurology, for reading this editorial and for his willingness to share his journal's resources with our readers. Disclosure Summary: The author has nothing to disclose.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Panjwani, N., Mulvihill, E. E., Longuet, C., Yusta, B., Campbell, J. E., Brown, T. J., Streutker, C., Holland, D., Cao, X., Baggio, L. L., et al. (2013) · Endocrinology · doi:10.1210/en.2012-1937 · Cited by 346
The Glucagon-Like Peptide-1 Receptor—or Not?
Pyke, C., & Knudsen, L. B. (2013) · Endocrinology · doi:10.1210/en.2012-2124 · Cited by 154
Cited by
Pyke, C., Heller, R. S., Kirk, R. K., Ørskov, C., Reedtz-Runge, S., Kaastrup, P., Hvelplund, A., Bardram, L., Calatayud, D., & Knudsen, L. B. (2014) · Endocrinology · doi:10.1210/en.2013-1934 · Cited by 876
“After recent changes in the editorial guidelines for publication of antibody-based data by this journal (26) and a recent review published in Diabetes that challenges the specificity of the antibodies used and some of the results obtained (27), it seems prudent to suggest that IHC data for GPCRs should always be exten…”
MethodHandelsman, D. J., & Wartofsky, L. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-3375 · Cited by 368
“When Endocrinology recently instituted the requirement for more rigorous reporting of antibody specificity, a few months were allowed for authors to come into compliance (30).”
BackgroundNever waste a good crisis: confronting reproducibility in translational research
Drucker, D. J. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.08.006 · Cited by 117
Glucagon‐like peptide‐1 receptor expression in the human eye
Hebsgaard, J. B., Pyke, C., Yildirim, E., Knudsen, L. B., Heegaard, S., & Kvist, P. H. (2018) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13339 · Cited by 88
Gotfredsen, C. F., Mølck, A.-M., Thorup, I., Nyborg, N. C. B., Salanti, Z., Knudsen, L. B., & Larsen, M. O. (2014) · Diabetes · doi:10.2337/db13-1087 · Cited by 60
“Some scientific journals have provided new guidance for validation experiments that must be available for reliable documentation of expression of a G-protein–coupled receptor (48).”
BackgroundIncretin drugs as modulators of atherosclerosis
Gallego-Colon, E., Wojakowski, W., & Francuz, T. (2018) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2018.09.011 · Cited by 35
Metadata
- Authors
- Gore, A. C.
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2013-02-01
- Volume
- 154
- Issue
- 2
- Pages
- 579-580
- ISSN
- 0013-7227 (ISSN-L)
- 1945-7170
- OpenAlex
- W1985697409
- Cited by
- 38
- References
- 2
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.